LCII vs BC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
LCII
54.1
AI Score
VS
BC Wins
BC
59.7
AI Score
Investment Advisor Scores
BC
60score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | LCII | BC | Winner |
|---|---|---|---|
| Revenue | 2.06B | 2.94B | BC |
| Net Income | 130.09M | 130.80M | BC |
| Net Margin | 6.3% | 4.5% | LCII |
| Operating Income | 191.12M | 179.70M | LCII |
| ROE | 9.1% | 7.8% | LCII |
| ROA | 4.0% | 2.4% | LCII |
| Total Assets | 3.27B | 5.51B | BC |
| Cash | 216.51M | 288.10M | BC |
| Debt/Equity | 0.60 | 1.08 | LCII |
| Current Ratio | 2.49 | 1.45 | LCII |
| Free Cash Flow | 141.79M | 151.10M | BC |
Relative Price Performance (Last 90 Days)
LCII 1M: -19.4%
· 3M: -20.7%
BC 1M: -12.1%
· 3M: -17.5%
Current Technical Phase
LCII
MarkdownSell / avoid
Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 30
BC
MarkdownSell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 32
Fundamentals Snapshot
| Metric | LCII | BC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.8 | 12.1 |
| Trailing P/E | 9.7 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.1% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 8.46 | -1.30 |
| Dividend Yield | 0.06% | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, BC is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.